1. Home >
  2. M&A >
  3. Divestiture >
  4. Canada >
  5. Ontario >
  6. Miravo Healthcare Acquires Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business

Divestiture • Life Science

Miravo Healthcare Acquires Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business

On September 19, 2018, Miravo Healthcare acquired life science company Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business from Aralez Pharmaceuticals for 110M USD

Acquisition Context
  • This is Miravo Healthcare’s 3rd transaction in the Life Science sector.
  • This is Miravo Healthcare’s 3rd largest (disclosed) transaction.
  • This is Miravo Healthcare’s 3rd transaction in Canada.
  • This is Miravo Healthcare’s 3rd transaction in Ontario.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary
Date September 19, 2018
Target Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business
Sector Life Science
Buyer(s) Miravo Healthcare
Sellers(s) Aralez Pharmaceuticals
Deal Type Divestiture
Deal Value 110M USD

Target Company

Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business

Milton, Ontario, Canada
Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business is a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Miravo Healthcare

Mississauga, Ontario, Canada
Category Company
Founded 1983
Sector Healthcare Services
Employees100
Revenue 69M CAD (2021)
DESCRIPTION

Miravo Healthcare is a specialty pharmaceutical company with a diverse portfolio of products and technologies. Miravo Healthcare was founded in 1983 and is based in Mississauga, Canada.

Deal Context for Buyer #
Overall 3 of 3
Sector: Life Science 3 of 3
Type: Divestiture 2 of 2
State: Ontario 3 of 3
Country: Canada 3 of 3
Year: 2018 3 of 3
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-10 Aralez Pharmaceuticals - VIMOVO Royalties

Milton, Ontario, Canada

Aralez Pharmaceuticals, Inc. - VIMOVO Royalties is a provider of biotechnological services in Milton, Canada.

Buy $110M

Seller Profile 1

SELLER

Aralez Pharmaceuticals

Milton, Ontario, Canada
Category Company
Founded 2015
Sector Life Science
Employees164
Revenue 106M USD (2017)
DESCRIPTION

Aralez Pharmaceuticals is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while focusing on creating shareholder value by acquiring, developing, and commercializing products primarily in cardiovascular, pain, and other specialty areas. Aralez Pharmaceuticals was founded in 2015 and is based in Mississauga, Canada.

Deal Context for Seller #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Divestiture 2 of 2
State: Ontario 2 of 2
Country: Canada 2 of 2
Year: 2018 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-10 Aralez Pharmaceuticals - VIMOVO Royalties

Milton, Ontario, Canada

Aralez Pharmaceuticals, Inc. - VIMOVO Royalties is a provider of biotechnological services in Milton, Canada.

Sell $110M

Explore Related M&A Activity

Life Science M&A - Divestiture M&A Deals - Ontario M&A - Canada M&A - 2018 M&A

Mergr

Solution for

Product

Company

Legal